Summit Therapeutics

Summit Therapeutics Net Margin

The Net Profit Margin of Summit Therapeutics (SMMT) as of Nov 22, 2026 is -11,095.77 %. In the previous year, Net Profit Margin was -4,895.03 % — a change of 126.67% (lower).

Net Margin

-11,095.77 %

YoY

126.67%

Last updated:

Net Profit Margin of Summit Therapeutics is 2022 -11,095.77 % . Net Profit Margin of Summit Therapeutics was 2021 -4,895.03 % . It decreases by 126.67% lower compared to the previous year.

Summit Therapeutics's net margin stands at -11,095.8%, down from 17.3% several years earlier.

The Summit Therapeutics Net Margin history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

Net Margin
Date
Net Margin
Jan 1, 2012
-2.34 USD
Jan 1, 2016
-929.13 USD
Jan 1, 2017
-163.66 USD
Jan 1, 2018
17.34 USD
Jan 1, 2019
-3,936.49 USD
Jan 1, 2020
-6,127.91 USD
Jan 1, 2021
-4,895.03 USD
Jan 1, 2022
-11,095.77 USD
The Summit Therapeutics Net Margin history
YEARNet MarginYoY
-11,095.77 %+126.67%
-4,895.03 %-20.12%
-6,127.91 %+55.67%
-3,936.49 %-22,800.41%
17.34 %-110.60%
-163.66 %-82.39%
-929.13 %+39,657.12%
-2.34 %+53.77%
-1.52 %-75.37%
-6.17 %-78.37%
-28.53 %-75.80%
-117.89 %+3,429.85%
-3.34 %+13.91%
-2.93 %+46.60%
-2.00 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Summit Therapeutics Stock analysis

What does Summit Therapeutics do? Summit Therapeutics Inc. is a global biopharmaceutical company focused on the discovery, development and commercialization of innovative medicines for the treatment of life-threatening and rare diseases. The company is headquartered in Massachusetts, USA and also has offices in Oxford, UK. Summit Therapeutics is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Summit Therapeutics stock

Net Profit Margin of Summit Therapeutics is -11,095.77 % in 2022.

Net Profit Margin of Summit Therapeutics changed from -4,895.03 % to -11,095.77 %, representing a 126.67% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of Net Profit Margin Summit Therapeutics since 2006 – with annual values, charts, and detailed analysis.

Net Margin measures the percentage of revenue that becomes net profit after all expenses. It is the ultimate measure of a company's profitability.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Net Profit Margin's Summit Therapeutics with sector peers and the industry average to assess whether it is attractive.

To evaluate Net Profit Margin's, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Net Profit Margin.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Margins — Summit Therapeutics

All Key Metrics — Summit Therapeutics